Navigation Links
Spacers Score Over Nebulizers in Childhood Asthma Treatment

Spacers and nebulizers-- two treatment methods for asthma attacks are found to be equal in staving off hospital admissions, a new review shows//. Spacer plays shorter stays in emergency departments usually for children.

The review authors, led by Christopher Cates, M.D., of the University of Alberta, in Edmonton, Canada, analyzed information from 25 studies of 2,066 children ages 2 years and older, and 614 adults with asthma. All used either spacers or nebulizers to deliver beta-2 agonists, medications that help ‘open’ the lungs to ease breathing in asthma attacks.

The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing medical trials on a topic.

A spacer is a holding chamber attached to devices for inhaling asthma medication. A nebulizer is an electrically powered machine that turns liquid medication into a mist breathed directly into the lungs through a face mask or mouthpiece. Nebulizers are the traditional method for treating asthma attacks, and are still used more often in hospitals.

The authors found that spacers and nebulizers work equally well for treating non–life-threatening asthma attacks, in terms of need for inpatient admission and the number of days in the hospital.

However, emergency room visits were almost one half-hour shorter for children who took their medication by spacers, and these children experienced fewer side effects, lower pulse rates and better oxygen delivery.

These advantages, along with ‘greater ease of use of spacers, together with hospital admission rates with spacers that are at best 60 percent lower than nebulizers and at worst 6 percent higher’ make the newer treatment ‘the recommended option for children,’ Cates sai d. He added that ‘nebulizers need a power supply, are less portable, require maintenance and are more difficult to clean than spacers.’

Carlos Camargo, Jr., M.D., Ph.D., of the Harvard School of Public Health, cautioned that the study results ‘apply to beta-agonist delivery only and not other agents, for example, inhaled corticosteroids.’ As for the most severely affected patients, ‘there are insufficient data on severe exacerbation to generalize to that high-risk group,’ Camargo said.

The authors conclude that the emergency- room results need to be replicated in a community setting. In the meantime, Cates said, the issue is ‘how to help people change practice from the familiar nebulization to using a spacer.’ He said that proper titration -- adjusting medication dose and timing according to symptoms -- is still ‘the key issue, whichever delivery method is used.’ An estimated 6.2 million U.S. children under age 18 years of age have asthma and 4 million of these had an asthma attack or episode in 2003, according to the American Lung Association. Asthma is the third leading cause of hospitalization in children under 15.

‘For adults seen and assessed for acute asthma, this review found no significant differences between the two delivery methods,’ the authors write. ‘Consequently, the choice of delivery method should reflect patient preference, practice situations and formal economic evaluation.’

Source: Eurekalert

Related medicine news :

1. Scorecard to help in diabetic risk assessment of the Indian Population
2. Scorecard to help in diabetic risk assessment of the Indian Population
3. PET-CT Scores High On Precision for Diagnosing Ovarian Cancer Recurrence
4. Milk Chocolate, Cinnamon, And Peppermint Scores Good For Brain
5. Breathing Exercises Scores Over Inhalers
6. NHS Employees Score Over Other Private Staffs In Taking Leave
7. CE Sonography Score Over Others in Blunt Abdominal Trauma Assessment
8. Warm Watermelon Scores Over Cold In Nutritive Value
9. Can Giving More Homework Improve Test Scores For Children?
10. Younger Siblings of Children With Autism Spectrum Disorders Score Low
11. Focused Treatment For Childhood Cancer
Post Your Comments:

(Date:11/25/2015)... ... ... For the first time, Vitalalert is donating half of its earnings to ... between the two groups began in 2014 with Vitalalert pledging a portion of every ... founded in 1954 and is an international Christian-based health organization whose mission is to ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... The McHenry ... a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. ... v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... in both surgical and non-surgical treatments, announced the expansion of his private practice ... Surgery. , Highly trained and nationally recognized for his natural approach, Dr. ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology: